Omar Al-Taweel

Dr. Omar Al-Taweel


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Cureus
Verified
Journal Article
Open access
ZGZaid Gheith
Zaid Gheith
AKAreej Kilani
Areej Kilani
OAOmar Al-Taweel
Omar Al-Taweel
Thrombotic thrombocytopenic purpura (TTP) is a multisystem disease characterized by disseminated thrombus formation in the arterioles and capillaries. Patients usually present with weakness, subtle mental changes, fever, and acute kidney injury. Cardiac symptoms, such as chest pain or arrhythmia, have been reported but were rarely the sole presenting symptom. We report the case of a 68-year-old woman with acute non-ST-elevation myocardial infarction who was found to have TTP. Prompt diagnosis of TTP is essential because traditional approaches to manage an acute coronary event, inclusive of dual antiplatelet therapy and percutaneous coronary intervention, might be contraindicated due to an increased risk of bleeding. Early administration of steroids and urgent initiation of plasmapheresis to improve platelet count would be crucial initial steps in the management of these patients.

Verified
Journal Article
Open access
PDF file
ABAsra K Butt
Asra K Butt
DADeya Alkhatib
Deya Alkhatib
IPIssa Pour-Ghaz
Issa Pour-Ghaz
SISakiru Oyetunji Isa
Sakiru Oyetunji Isa
OAOmar Al-Taweel
Omar Al-Taweel
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy resulting from a mutation in one of several cardiac sarcomeric proteins

Verified
Journal Article
Open access
PDF file
DADeya Alkhatib
Deya Alkhatib
SISakiru Oyetunji Isa
Sakiru Oyetunji Isa
IPIssa Pour-Ghaz
Issa Pour-Ghaz
ABAsra K Butt
Asra K Butt
OAOmar Al-Taweel
Omar Al-Taweel
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
Heart failure (HF) therapeutics have advanced significantly over the past few years

11 March 2023 in CJC Open
Verified
Journal Article
Open access
OAOmar Al-Taweel
Omar Al-Taweel
AGAhmad Gill
Ahmad Gill
YAYousif Al-Baghdadi
Yousif Al-Baghdadi
SMSalman Mohammed
Salman Mohammed
WJWilbur Ji
Wilbur Ji
CAChowdhury Ahsan
Chowdhury Ahsan
Nonelective transcatheter aortic valve replacement (TAVR) requires additional research to be fully understood. Using the National Inpatient Sample database (2016-2019), we conducted a retrospective cohort study comparing nonelective vs elective TAVR. The primary outcome of interest was the in-hospital mortality rate among patients undergoing nonelective TAVR, compared to that among patients undergoing elective TAVR. We matched patients in a greedy nearest-neighbor 1:1 model and multivariable logistic regression, which was adjusted for demographics, hospital factors, and comorbidities, and was used to compare mortality in our matched cohort. Each cohort had 4389 patients in each cohort. When adjusted for age, race, sex, and comorbidities, nonelective TAVR patients had 1.99 times higher odds of suffering in-hospital mortality compared to elective admissions (adjusted odds ratio 1.99, 95% confidence interval: 1.42-2.81; P < 0.001). When separated by transfer status, nonelective patients admitted as regular hospital admissions or transferred from other acute-care centres also had higher odds of suffering in-hospital mortality compared to elective admissions. Our findings illustrate that nonelective TAVR patients are a vulnerable population that require additional medical support in the acute-care setting. As the demand for TAVR increases, further discussions regarding access to healthcare in underserved regions, the national physician shortage, and the future of the TAVR industry are imperative.

Verified
Journal Article
Open access
PDF file
IPIssa Pour-Ghaz
Issa Pour-Ghaz
DADeya Alkhatib
Deya Alkhatib
SISakiru Oyetunji Isa
Sakiru Oyetunji Isa
OAOmar Al-Taweel
Omar Al-Taweel
IUIfeoma Ugonabo
Ifeoma Ugonabo
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
One of the major risk factors for coronary atherosclerosis is the gradual formation and maturation of coronary atherosclerotic plaque (CAP)